Literature DB >> 26465978

Chitosan Nanoparticles for Nuclear Targeting: The Effect of Nanoparticle Size and Nuclear Localization Sequence Density.

Salma N Tammam1,2, Hassan M E Azzazy2, Hans G Breitinger3, Alf Lamprecht1,4.   

Abstract

Many recently discovered therapeutic proteins exert their main function in the nucleus, thus requiring both efficient uptake and correct intracellular targeting. Chitosan nanoparticles (NPs) have attracted interest as protein delivery vehicles due to their biocompatibility and ability to escape the endosomes offering high potential for nuclear delivery. Molecular entry into the nucleus occurs through the nuclear pore complexes, the efficiency of which is dependent on NP size and the presence of nuclear localization sequence (NLS). Chitosan nanoparticles of different sizes (S-NPs ≈ 25 nm; L-NP ≈ 150 nm) were formulated, and they were modified with different densities of the octapeptide NLS CPKKKRKV (S-NPs, 0.25, 0.5, 2.0 NLS/nm(2); L-NPs, 0.6, 0.9, 2 NLS/nm(2)). Unmodified and NLS-tagged NPs were evaluated for their protein loading capacity, extent of cell association, cell uptake, cell surface binding, and finally nuclear delivery efficiency in L929 fibroblasts. To avoid errors generated with cell fractionation and nuclear isolation protocols, nuclear delivery was assessed in intact cells utilizing Förster resonance energy transfer (FRET) fluorometry and microscopy. Although L-NPs showed ≈10-fold increase in protein loading per NP when compared to S-NPs, due to higher cell association and uptake S-NPs showed superior protein delivery. NLS exerts a size and density dependent effect on nanoparticle uptake and surface binding, with a general reduction in NP cell surface binding and an increase in cell uptake with the increase in NLS density (up to 8.4-fold increase in uptake of High-NLS-L-NPs (2 NLS/nm(2)) compared to unmodified L-NPs). However, for nuclear delivery, unmodified S-NPs show higher nuclear localization rates when compared to NLS modified NPs (up to 5-fold by FRET microscopy). For L-NPs an intermediate NLS density (0.9 NLS/nm(2)) seems to provide highest nuclear localization (3.7-fold increase in nuclear delivery compared to High-NLS-L-NPs). Results indicate that a higher NLS density does not result in maximum protein nuclear localization and that a universal optimal density for NPs of different sizes does not exist.

Keywords:  FRET; active targeting; chitosan nanoparticles; nuclear delivery; nuclear localization sequence; nuclear localization sequence density; nuclear targeting; protein delivery

Mesh:

Substances:

Year:  2015        PMID: 26465978     DOI: 10.1021/acs.molpharmaceut.5b00478

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  13 in total

Review 1.  Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.

Authors:  Alvin J Mukalel; Rachel S Riley; Rui Zhang; Michael J Mitchell
Journal:  Cancer Lett       Date:  2019-05-14       Impact factor: 8.679

Review 2.  Tumor heterogeneity and nanoparticle-mediated tumor targeting: the importance of delivery system personalization.

Authors:  K Laxmi Swetha; Aniruddha Roy
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  In Vitro Methods for Assessing Nanoparticle Toxicity.

Authors:  Dustin T Savage; J Zach Hilt; Thomas D Dziubla
Journal:  Methods Mol Biol       Date:  2019

4.  Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.

Authors:  Zachary R Stephen; Peter A Chiarelli; Richard A Revia; Kui Wang; Forrest Kievit; Chris Dayringer; Mike Jeon; Richard Ellenbogen; Miqin Zhang
Journal:  Cancer Res       Date:  2019-07-22       Impact factor: 12.701

5.  Trends in the Design and Evaluation of Polymeric Nanocarriers: The In Vitro Nano-Bio Interactions.

Authors:  Ana Bettencourt; Lídia M Gonçalves
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 6.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

7.  pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery.

Authors:  Zhe Liu; Dong Zhou; Lan Liao
Journal:  Front Bioeng Biotechnol       Date:  2022-04-11

Review 8.  Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio-Nano Interface.

Authors:  Joshua D Simpson; Samuel A Smith; Kristofer J Thurecht; Georgina Such
Journal:  Polymers (Basel)       Date:  2019-09-02       Impact factor: 4.329

9.  Nuclear delivery of recombinant OCT4 by chitosan nanoparticles for transgene-free generation of protein-induced pluripotent stem cells.

Authors:  Salma Tammam; Peter Malak; Daphne Correa; Oliver Rothfuss; Hassan M E Azzazy; Alf Lamprecht; Klaus Schulze-Osthoff
Journal:  Oncotarget       Date:  2016-06-21

10.  Intracellular Delivery of Proteins into Living Cells by Low-Molecular-Weight Polyethyleneimine.

Authors:  Yueheng Wu; Lin Jiang; Zixuan Dong; Shaoxian Chen; Xi-Yong Yu; Shunqing Tang
Journal:  Int J Nanomedicine       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.